The effect of rhIGF-1 and insulin analogue AspB10 on mammary tumour growth and progression in a mouse model of type 2 diabetes

被引：0
|
作者：
Gallagher, E. J. [1 ]
Alikhani, N. [1 ]
Tobin-Hess, A. [1 ]
Cannata, D. [1 ]
Tennagels, N. [2 ]
Werner, U. [2 ]
LeRoith, D. [1 ]
机构：
[1] Mt Sinai Sch Med, Samuel Bronfman Dept Med, New York, NY USA
[2] Sanofi, R&D Diabet Div, Frankfurt, Germany
来源：
DIABETOLOGIA | 2012年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
706
引用
收藏
页码：S289 / S289
页数：1
相关论文
共 41 条
  • [1] The Effect of rhIGF-1 on Mammary Tumor Growth and Progression in a Mouse Model of Type-2 Diabetes
    Alikhani, Nyosha
    Tobin-Hess, Aviva
    Cohen, Dara
    Leroith, Derek
    Gallagher, Emily
    DIABETES, 2012, 61 : A683 - A684
  • [2] Mammary gland tumor promotion by chronic administration of IGF1 and the insulin analogue AspB10 in the p53R270H/+WAPCre mouse model
    Bas ter Braak
    Christine Siezen
    Ewoud N Speksnijder
    Esmee Koedoot
    Harry van Steeg
    Daniela CF Salvatori
    Bob van de Water
    Jan Willem van der Laan
    Breast Cancer Research, 17
  • [3] Mammary gland tumor promotion by chronic administration of IGF1 and the insulin analogue AspB10 in the p53R270H/+WAPCre mouse model
    ter Braak, Bas
    Siezen, Christine
    Speksnijder, Ewoud N.
    Koedoot, Esmee
    van Steeg, Harry
    Salvatori, Daniela C. F.
    van de Water, Bob
    van der Laan, Jan Willem
    BREAST CANCER RESEARCH, 2015, 17
  • [4] Down-regulation of cyclin G2 by insulin, IGF-I (insulin-like growth factor 1) and X10 (AspB10 insulin): role in mitogenesis
    Svendsen, Angela M.
    Winge, Sofia B.
    Zimmermann, Maike
    Lindvig, Anne B.
    Warzecha, Caroline B.
    Sajid, Waseenn
    Horne, Mary C.
    De Meyts, Pierre
    BIOCHEMICAL JOURNAL, 2014, 457 : 69 - 77
  • [5] Combination recombinant human insulin-like growth factor 1 (rhIGF-1) and IGF binding protein 3 (BP)[SomatoKine] reduces insulin requirements and improves glycemic control in type 1 diabetes (DM)
    Moses, AC
    Sommer, A
    McKay, M
    David, R
    Ruckle, JL
    David, C
    DIABETES, 1999, 48 : A93 - A93
  • [6] Peripheral pain is enhanced by insulin-like growth factor 1 and its receptors in a mouse model of type 2 diabetes mellitus
    Tang, Zhaosheng
    Cao, Fuming
    Zhang, Hao
    Tang, Jin
    Li, Huizhi
    Zhang, Yiyun
    Feng, Bo
    Wang, Hua
    JOURNAL OF DIABETES, 2019, 11 (04) : 309 - 315
  • [7] Weight-HbA1c-Insulin-Glucose Model for Describing Disease Progression of Type 2 Diabetes
    Choy, S.
    Kjellsson, M. C.
    Karlsson, M. O.
    de Winter, W.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2016, 5 (01): : 11 - 19
  • [8] Effect of γ-aminobutyric acid-rich yogurt on insulin sensitivity in a mouse model of type 2 diabetes mellitus
    Li, Xiangfei
    Chen, Lin
    Zhu, Xiaoyu
    Lu, Zhaoxin
    Lu, Yingjian
    JOURNAL OF DAIRY SCIENCE, 2020, 103 (09) : 7719 - 7729
  • [9] Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
    Gallagher, Emily J.
    Zelenko, Zara
    Tobin-Hess, Aviva
    Werner, Ulrich
    Tennagels, Norbert
    LeRoith, Derek
    DIABETOLOGIA, 2016, 59 (09) : 2018 - 2025
  • [10] Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
    Emily J. Gallagher
    Zara Zelenko
    Aviva Tobin-Hess
    Ulrich Werner
    Norbert Tennagels
    Derek LeRoith
    Diabetologia, 2016, 59 : 2018 - 2025
12345